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Abstract
Background: The dead-end (Dnd1) gene is essential for maintaining the viability of germ cells. Inactivation of Dnd1 results in
sterility and testicular tumors. The Dnd1 encoded protein, DND1, is able to bind to the 39-untranslated region (UTR) of
messenger RNAs (mRNAs) to displace micro-RNA (miRNA) interaction with mRNA. Thus, one function of DND1 is to prevent
miRNA mediated repression of mRNA. We report that DND1 interacts specifically with APOBEC3. APOBEC3 is a multi-
functional protein. It inhibits retroviral replication. In addition, recent studies show that APOBEC3 interacts with cellular
RNA-binding proteins and to mRNA to inhibit miRNA-mediated repression of mRNA.
Methodology/Principal Findings: Here we show that DND1 specifically interacts with another cellular protein, APOBEC3.
We present our data which shows that DND1 co-immunoprecipitates APOBEC3 from mammalian cells and also endogenous
APOBEC3 from mouse gonads. Whether the two proteins interact directly remains to be elucidated. We show that both
DND1 and APOBEC3 are expressed in germ cells and in the early gonads of mouse embryo. Expression of fluorescently-
tagged DND1 and APOBEC3 indicate they localize to the cytoplasm and when DND1 and APOBEC3 are expressed together
in cells, they sequester near peri-nuclear sites.
Conclusions/Significance: The 39-UTR of mRNAs generally encode multiple miRNA binding sites as well as binding sites for
a variety of RNA binding proteins. In light of our findings of DND1-APOBEC3 interaction and taking into consideration
reports that DND1 and APOBEC3 bind to mRNA to inhibit miRNA mediated repression, our studies implicate a possible role
of DND1-APOBEC3 interaction in modulating miRNA-mediated mRNA repression. The interaction of DND1 and APOBEC3
could be one mechanism for maintaining viability of germ cells and for preventing germ cell tumor development.
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Introduction
The Dnd1 gene is essential for primordial germ cell survival in
vertebrates from zebrafish, xenopus to mice [1–3]. Loss of Dnd1
expression in primordial germ cells results in their death during
embryogenesis, thus causing sterility in adults. In 129 strain mice,
inactivation of Dnd1, as in the 129-Ter mouse strain, causes loss of
germ cells and in addition, development of testicular germ cell
tumors [3]. Germ cell tumor development in 129-Ter/Ter (Dnd1-/-)
mice is also initiated during embryonic stages [4–7].
Based on analysis using the NCBI conserved domain database
(CDD), the mouse Dnd1 protein, DND1, has at least one RNA
recognition motif (RRM) [3]. DND1 has been shown to bind to
the 39-UTR of mRNAs to displace miRNAs that bind to adjacent
sites on the same mRNA [8]. miRNA are small RNAs (20–22 nt)
that regulate gene expression, mainly by post-transcriptional
processes [9–11]. Evidence indicates that binding of DND1 to
the 39-UTR of p27 or LATS2 mRNA hinders access of miR-221
or miR-372, respectively [8,12]. This results in increased p27 or
LATS2 protein levels because DND1 inhibits miRNA-mediated
repression of protein expression.
As DND1 is specifically expressed in germ cells, it serves to
differentially regulate expression of mRNA in germ cells. During
early development, germ cells are set aside from the somatic cells
of the embryo on the basis of differential regulation of mRNA in
germ cells compared to somatic cells [13,14]. For example, in
zebrafish germ cells, Dnd1 binds to nanos1 and tdrd7 mRNA to
displace miR-430 binding to mRNA. This prevents miR-430
mediated inhibition of nanos1 and tdrd7 expression in germ cells
[8]. In contrast, miR-430 inhibits nanos1 and tdrd7 expression in
somatic cells because somatic cells do not express Dnd1. These
observations provide an explanation as to why lack of Dnd1 in
germ cells causes loss of expression of germ cell specific proteins
therefore resulting in germ cell death. However, it is not clear why
lack of Dnd1 causes germs cells to become transformed as in the
Ter mouse strain. One possibility is that absence of DND1 may
cause deficiency of tumor suppressor proteins and this may cause
germ cell tumor development.
Mouse DND1 protein shows highest homology to ACF
(APOBEC1 complementation factor) [5,3]. The overall amino
acid identity between DND1 and ACF is 34%. There is 48%
identity between the RNA recognition motif (RRM) of DND1 and
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2315the first RRM of ACF (Fig. 1a). ACF is the essential RNA-binding
co-factor of APOBEC1 and together they comprise the RNA
editing enzyme complex (editosome) [15,16]. APOBEC1 together
with ACF converts specific cytidines to uridines in the apolipo-
protein B transcript and other mRNAs. On the basis of the
homology between DND1 and ACF, we hypothesized that DND1,
like ACF, may interact with APOBEC-like proteins.
APOBEC proteins are present in vertebrates from zebrafish to
man [17]. Members of the family have zinc-binding domains with
homology to bacterial cytidine deaminase. The APOBEC family
members in the mouse that have RNA or DNA deaminase
activity, or both are: APOBEC1, APOBEC2, APOBEC3 and
AICD (activation-induced cytidine deaminase; also known as
AID). The function of APOBEC2 is not known. It is expressed
mainly in muscle cells [18] and has lower, but still detectable
cytidine deaminase activity compared to APOBEC1. APOBEC3,
is expressed in the testes, adult germ cells [19] and a wide variety
of tissues. Human APOBEC3 is able to hypermutate the cDNA
derived during replication of exogenous and endogenous retrovi-
ruses in cells. Thus APOBEC3 inhibits viral replication [20] and
functions to maintain innate immunity of cells. AICD is found
mainly in B-cells and is involved in class-switch recombination and
somatic hypermutation of antibody genes [21]. Deamination
within the immunoglobulin loci by AICD initiates antibody gene
diversification. A new Apobec gene family member, Apobec4 was
recently identified by genomic analysis but its protein and enzyme
function has not been determined [22]. Mice and humans encode
one gene each for APOBEC1, APOBEC2, APOBEC4 and AICD.
The mouse genome also encodes one Apobec3 gene on chromo-
some 15. However, in humans there has been an expansion of the
APOBEC3 gene family such that eight APOBEC3 genes are
tandemly encoded on human chromosome 22q13.1 [17,19].
These genes are designated APOBEC3A to APOBEC3H. Of these,
APOBEC3G and APOBEC3F have been extensively studied
because of their ability to restrict human immunodeficiency virus
(HIV) [23–25].
Aberrant expression of APOBECs in the cell has been proposed
to cause promiscuous nucleotide modification and genomic
instability [26]. Human APOBEC1 and APOBEC3 exhibit
DNA mutator activity in Escherichia coli assays [27]. They caused
DNA mutation through cytidine (dC) deamination and demon-
strated target sequence specificity. Thus, APOBEC proteins are
potential mutators and this has possible implications in cancer
development. Because APOBECs have the potential ability to
mutate cellular nucleic acids, their activity in cells is likely to be
tightly regulated.
Recent studies on APOBEC3 indicate that it possesses cellular
functions in addition to its ability to restrict retroviruses and
retrotransposons. Human APOBEC3 was found to prevent
microRNA-mediated inhibition of protein translation [28]. This
did not require the cytidine deaminase activity of APOBEC3G. In
addition, a number of reports now show that APOBEC3G
interacts with a variety of RNA-binding proteins and locates to P-
bodies and stress granules [29–31]. Very interestingly, this novel
function of APOBEC3 parallels the role of DND1 in inhibiting
miRNA function.
We investigated whether mouse DND1 can interact with any of
the APOBEC proteins. Here, we report that DND1 can interact
specifically with APOBEC3. In light of recent reports pertaining to
modulation of miRNA function by both DND1 and APOBEC3, it
is likely that these two proteins may act synergistically or oppose
each other to modulate miRNA function.
Results
Isolation of Apobec cDNAs from testes of 129 mice
We previously found that inactivation of Dnd1 results in sterility
as well as increased testicular tumors in the 129 mouse strain [3].
Figure 1. (a) Comparing DND1 and ACF. Representation of DND1a, DND1b and ACF proteins, drawn to scale. RNA recognition motif (RRM) is
indicated in orange. ACF possesses 2 additional RRMs not found in DND1 as well as a double-stranded RNA binding motif (DSRM). The protein
structure analyses are from NCBI conserved domain database (CDD). (b) Comparing APOBEC proteins. The protein coding regions of APOBEC1,
APOBEC2, APOBEC3 (8 exon isoform) and APOBEC3 (9 exon isoform) are compared. The cytidine deaminase (CD) domains are indicated in green.
APOBEC3 possesses 2 cytidine deaminase domains, which are not functionally equivalent. The protein structure analyses are from NCBI conserved
domain database (CDD). (c) RT-PCR amplifies Apobec1, Apobec2 and Apobec3 from mRNA of 129 mouse testes. Transcripts of both isoforms
of Apobec3 (with 8 and 9 exons, respectively) are indicated by the doublet band (arrow).
doi:10.1371/journal.pone.0002315.g001
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(APOBEC1 complementation factor) (Fig. 1a). We sought to
determine if DND1, like ACF [15,16], has the ability to interact
with any of the APOBEC family proteins that are normally
expressed in mouse testes.
As a first step, we determined the Apobec transcripts that are
present in mouse testes. We designed primers to specifically amplify
Apobec transcripts from RNA derived from the testes of the 129
mouse strain. RT-PCR amplified Apobec1, Apobec2 and two isoforms
of Apobec3 (Fig. 1c). Sequencing of the RT-PCR products indicated
that we had isolated two isoforms of Apobec3 that differ because they
contain 8 and 9 exons, respectively (Fig. 1b). The 8-exon Apobec3
isoform has an amino acid sequence identical to that of the 9-exon
isoform except that it lacks 33 amino acids in the central part of the
protein. The 8-exon isoform is translated from an alternately spliced
mRNA that skips exon 5 of Apobec3 yet retains the same reading
frame. These two isoforms of mouse Apobec3 have been previously
described in the database [http://www.ensembl.org/Mus_musculus/
geneview?gene=ENSMUSG00000009585].
Although Apobec1 and Apobec2 have not previously been reported
to be present in the testes, we were able to detect their transcripts
by RT-PCR indicating that low levels of these Apobecs are in fact
present in the testes. We were unable to isolate the AICD transcript
from testes RNA possibly because its expression is restricted to B-
lymphocytes. The full-length cDNAs of the Apobec genes were
cloned into pBK-CMV vectors (Stratagene), sequence-verified and
used as templates for in vitro transcription and translation reactions
to generate [
35S]methionine-labeled APOBEC proteins.
DND1 interacts with APOBEC proteins in vitro
The TnT Coupled Reticulocyte Lysate Systems (Promega) was
used to generate [
35S]methionine-labeled APOBEC proteins in in
vitro transcription and coupled translation reactions (see Experi-
mental Procedures section) (Fig. 2b). For controls, human
APOBEC1 (hA1) and human ACF were also generated by in vitro
transcription/translation of cloned expression constructs (Fig. 2e).
The sizes and amount of translated [
35S]methionine-labeled
APOBEC protein products were determined by electrophoreses.
To test whether any of the APOBEC family members can
interact with DND1 in vitro,[
35S]methionine-labeled APOBEC
proteins were incubated with purified GST(glutathione S-trans-
ferase)-DND1 [32] (Fig. 2a). Glutathione (GST) Sepharose 4B
beads were then added to the mix. In control reactions, equal
amounts of [
35S]methionine-labeled APOBEC proteins were
incubated with beads only. The glutathione Sepharose 4B beads
bind to the GST moiety of GST-fusion proteins (in this case, GST-
DND1) and should therefore ‘‘pull-down’’ proteins that associate
with GST-DND1. At the end of the incubation period, the
Sepharose 4B beads were pelleted and washed to reduce non-
specific binding. The proteins bound to the beads were released
into loading dye by heating, prior to electrophoreses. In a second
control, [
35S]methionine-labeled APOBEC proteins were incu-
bated with purified GST protein and beads (Fig. 2a and f).
These results show that APOBEC3 is able to specifically bind to
GST-DND1. Both isoforms of APOBEC3, the 9-exon isoform and
the 8-exon isoform, showed specific binding to GST-DND1a
(Fig. 2c, lanes 5–8) and GST-DND1b (Fig. 2d, lanes 3–6). The
binding of APOBEC3 is specific to the DND1 moiety of GST-
DND1 because APOBEC3 did not bind to GST protein (Fig. 2f) or
to the beads (Fig. 2c, lanes 6 & 8, and Fig. 2d, lanes 4 & 6). Mouse
and human APOBEC1 were also able to bind to GST-DND1 but
therewassignificantnon-specificbindinginthecontrollanes(Fig.2c,
d and e, lanes 1 & 2). Thus, APOBEC1 may also be able to bind to
DND1 but with lower affinity compared to APOBEC3. APOBEC2
or ACF did not bind to GST-DND1 (Fig. 2e).
Further, we tested whether the in vitro binding of GST-DND1 to
APOBEC3 is dependent on RNA or DNA that may be present in
the in vitro transcription/translation reactions. However, treatment
of [
35S]methionine-labeled APOBEC3-GST-DND1 complexes
with excess RNase or DNase did not affect binding of the two
proteins (Fig. 2g). This indicates that any RNA or DNA present in
the TnT coupled transcription/translation rabbit reticulocyte
lysates (Promega) was not involved in promoting binding of
APOBEC3 to DND1. In summary, the data indicates that
APOBEC3 is able to specifically bind to DND1. These
experiments provided the first evidence that DND1 can interact
directly with APOBEC3.
DND1 interacts with APOBEC3 in mammalian cells
Next, we tested whether DND1 can interact with APOBEC
proteins in mammalian cells. HA-tagged Dnd1 and myc-tagged
Apobec plasmid constructs were co-transfected into 293T cells. myc-
APOBEC1, 2, and 3 expression in transfected 293T cells were
detected by immunoblotting with anti-myc (Fig. 3a, top panel).
Expression of HA-tagged DND1 was also detected using anti-
DND1 antibody, antibody C [32] (Fig. 3a, lower panel). The
lysates were used for immunoprecipitation with anti-HA antibody
to ‘‘pull-down’’ HA-DND1 and associated proteins. No antibody
was added to controls. After immunoprecipitation with anti-HA
antibody, electrophoresis and transfer to membranes, western
blotting was performed using anti-myc antibody.
The results showed that myc-APOBEC3 was ‘‘pulled-down’’
specifically with HA-DND1 (Fig. 3b, lane 13). In contrast, myc-
APOBEC1 and myc-APOBEC2 were not ‘‘pulled-down’’ by HA-
DND1 (Fig. 3b, lanes 9 and 11).
These results are evidence that DND1 can associate with
APOBEC3 in mammalian cells. This in vivo pull-down of tagged
proteins is a second technique used to validate the previous in vitro
binding results. Interaction of APOBEC3 to GST-DND1 in vitro is
likely because of direct binding of APOBEC3 to GST-DND1
whereas ‘‘pull-down’’ of myc-APOBEC3 by HA-DND1 from cell
lysates suggests interaction of the proteins but which may not
necessarily be due to direct binding. Additional co-factors present
in mammalian cells could bridge the interactions between the HA-
DND1 and myc-APOBEC3 proteins. To summarize, the in vivo
pull down experiment in 293T cells demonstrates that DND1 and
APOBEC3 are present in the same protein complexes in
mammalian cells.
DND1 ‘‘pulls-down’’ endogenous APOBEC3 from mouse
testes
We next tested whether DND1 interacts with APOBEC3 in
mouse tissues. Both DND1 and APOBEC3 are expressed in adult
testes [32,33,3]. Because antibodies for immunoprecipitation of
DND1 are currently not available, we used purified GST-DND1
to perform in vivo ‘‘pull-down’’ experiments. We incubated GST-
DND1 protein with mouse testes lysate. The GST-DND1 was
then incubated with Sepharose 4B beads to pull down GST-
DND1 and any associated proteins. The beads were subsequently
washed, and then boiled in loading dye prior to electrophoresis
and transfer to membranes. To detect APOBEC3, immunoblot-
ting was performed with polyclonal, rabbit anti-mouse APOBEC3
antibody (Upstate). This antibody detects an epitope in the N-
terminus of mouse APOBEC3.
Our results showed that GST-DND1a was able to ‘‘pull-down’’
APOBEC3frommousetestes(Fig.4a).APOBEC3frommousetestis
was the same size as myc-APOBEC3 expressed in cells transfected
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PLoS ONE | www.plosone.org 3 May 2008 | Volume 3 | Issue 5 | e2315Figure 2. DND1 interacts with APOBEC3 in vitro. (a) Experimental design to test interaction of DND1 to the APOBEC proteins in vitro.
All reactions contained [
35S]methionine-labeled APOBEC proteins (blue circles). The labeled proteins were incubated with purified GST-DND1
(indicated by+in panels c–e). Glutathione Sepharose 4B beads (beads, white circles) were added to the reactions. The beads are able to bind to the
GST moiety of DND1 and should also ‘‘pull-down’’ proteins that associate with GST-DND1. Control incubations used beads alone incubated with
labeled APOBEC proteins (indicated by–in panels c–e). (b) In vitro transcribed/translated [
35S]methionine-labeled APOBEC proteins. 5 mL
was loaded from each translation reaction. A1 (APOBEC1), A2 (APOBEC2), A3 (8) (8-exon isoform APOBEC3) and A3 (9) (9-exon isoform of APOBEC3).
The translated proteins used as input are marked with red bars (in panels b, d–f). (c) Binding of APOBEC proteins to GST-DND1a.4 0mLo f
[
35S]methionine-labeled APOBEC proteins was incubated with GST beads and either with (+) or without (2) GST-DND1a. Lanes 5 and 7 show binding
of APOBEC3 to GST-DND1a. Lanes 6 and 8 show no binding of APOBEC3 to the beads. (d) Binding of APOBEC proteins to GST-DND1b.4 0mLo f
[
35S]methionine-labeled APOBEC proteins (APOBEC1 and both isoforms of APOBEC3) were incubated with GST beads and either with (+) or without
(2) GST-DND1b. Lanes 3 and 5 show binding of APOBEC3 to GST-DND1b. Lanes 4 and 6 show no binding of APOBEC3 to the beads. Lanes, 7, 8 and 9
are the translated proteins used as input (5 mL). (e) Testing interaction of human APOBEC1 and ACF to GST-DND1a.4 0 mLo f
[
35S]methionine-labeled human APOBEC1 (hA1), mouse APOBEC2 (A2) and human ACF were incubated with GST beads and either with (+) or without
(2) GST-DND1a. Comparison of lanes 1 and 2 indicate weak binding of human APOBEC1 (hA1) to GST-DND1a. Comparison of lanes 5 and 6 indicate
no specific binding of ACF to GST-DND1a. Lanes, 7, 8 and 9 are the translated proteins used as input (5 mL). (f) Binding of APOBEC proteins to
GST (second control).4 0mLo f[
35S]methionine-labeled APOBEC proteins (APOBEC1 and both isoforms of APOBEC3) were incubated with GST
beads and either with (+) or without (2) GST. Lanes, 7, 8 and 9 are the translated proteins used as input (5 mL). (g) Effect of RNase (left) and
DNase (right) on APOBEC3 and GST-DND1 interaction.[
35S]methionine-labeled APOBEC proteins incubated together with GST-DND1a ˜ and
GST beads were divided into two. Each aliquot was treated with RNase (+) or DNAse (+) or not treated (2) prior to electrophoresis.
doi:10.1371/journal.pone.0002315.g002
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GST-DND1b was not able to efficiently ‘‘pull-down’’ APOBEC3
from mouse testes and this suggests that DND1a isoform interacts
more efficiently with endogenous, testes APOBEC3. DND1a
isoform is expressed in germ cells during embryogenesis as well as
in adult stages. In contrast, DND1b is expressed in meiotic and post-
meiotic germ cells in adult mice [32].
Apobec3 transcripts in mouse germ cells and developing
gonads
Germ cell tumors arise in the developing gonads (genital ridges)
of the male embryo. Dnd1 transcripts are detected in germ cells
soon after germ cell specification [34] and in mouse embryonic
gonads (genital ridges) [32,3]. Dnd1 encoded protein, DND1, is
also expressed in embryonic germ (EG) cells grown in culture
Figure 3. DND1 interacts with APOBEC3 in mammalian cells. (a) Expression of APOBEC proteins and DND1 in 293T transfected cells.
Cells were co-transfected with expression vectors encoding HA-tagged Dnd1 (lanes 1, 2, 3 & 4) and myc-tagged Apobec1, Apobec2 and Apobec3 (lanes
2, 3 & 4, respectively). After 48 h, transfected cells were lysed. An aliquot (10 mg) was electrophoresed for western blotting with anti-myc (top panel)
and anti-DND1 antibody (bottom panel) to detect expression of proteins. (b) HA-DND1 pulls-down APOBEC3 from cells. Lysates from
transfected cells in (a) were used. Equal aliquots (50 mg) were used for immunoprecipitation (IP) using anti-HA antibody (+) to pull down HA-DND1
(lanes 6, 7, 9, 11 & 13). Control lanes had no antibody (2). Following IP, electrophoresis and transfer to membranes, western blotting was performed
using anti-myc antibody.
doi:10.1371/journal.pone.0002315.g003
Figure 4. DND1 and APOBEC3 in mouse tissues. (a) DND1 interacts with endogenous APOBEC3. Mouse testis lysates were incubated
with GST-DND1a (lane 1), GST-DND1b . (lane 2) or GST protein (lane 3) and incubated with Sepharose 4B beads. The beads were washed and the
contents eluted into loading dye prior to electrophoresis and immunoblotting with rabbit anti-mouse APOBEC3 antibody. Control lanes on the left
are cell lysates from untransfected cells (lane 4) and lysates from cells transfected with myc-APOBEC3 expression constructs (lane 5). (b) Dnd1 and
Apobec3 are expressed in embryonic germ (EG) cells and genital ridges. RT-PCR for Apobec3, Dnd1 and HPRT (hypoxanthine-guanine
phosphoribosyltransferase) on total RNA from EG cells, mouse embryo fibroblasts (MEF), and E13.5 genital ridges (GR). (c) EG cells in culture, stained
with alkaline phosphatase (orange clusters), growing on MEF cell layer.
doi:10.1371/journal.pone.0002315.g004
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primordial germ cells of embryos of embryonic (E) 8.5 –E 11.5
stages from hybrid strains of B6C3 F1 mice [35,36]. Although
expression of Apobec3 in adult tissues has been described [37], the
expression of Apobec3 in embryonic stages has not been examined.
We therefore examined the expression of both Dnd1 and Apobec3
transcripts in embryonic germ (EG) cells and in genital ridges
(embryonic gonads).
RT-PCR indicated the presence of Apobec3 and Dnd1 transcripts
in EG cells (Fig. 4b). Apobec3 and Dnd1 were not detected in RNA
from mouse embryo fibroblasts (MEFs), which are the feeder cell
layers on which EG cells grow (Fig. 4c).
In addition, we also isolated embryonic gonads (genital ridges)
from129 strain,maleE13.5 embryos.RT-PCR for Apobec3 and Dnd1
transcripts was carried out on total RNA prepared from the E13.5
genital ridges. Dnd1 and Apobec3 transcripts are expressed in E13.5
genital ridges (Fig. 4b). Interestingly, RT-PCR indicated that EG
cells express higher levels of the shorter, 8-exon isoform of Apobec3
compared to that in the genital ridges. One reason for this could be
because the EGcells are derived from a different mousestrain, B6C3
hybrid, whereas the genital ridges are from 129. In conclusion, we
demonstrate that both Apobec3 and Dnd1 are expressed in embryonic
gonads and in embryonic germ cells of the mouse.
DND1 and APOBEC3 sequester to peri-nuclear sites
To visualize the cellular localization of the DND1 and
APOBEC3, we transfected expression plasmids encoding GFP-
Dnd1 and mCherry-Apobec3 into different mammalian cells such as
COS7, NIH3T3 and 293T cells. The transfected cells were
observed using a Zeiss LSM 510 confocal microscope. Overall,
when either GFP-DND1 or mCherry-APOBEC3 were transfected
in cells, the expression of the fluorescent-tagged proteins was
predominantly in the cytoplasm (Fig. 5a and d). However, when
both GFP-DND1 and mCherry-APOBEC3 were co-transfected in
COS7 cells, we observed a sharp overlap of the green and red
signals to form a ring-like zone surrounding the nucleus indicating
co-localization of the GFP-DND1 and mCherry-APOBEC3
fluorescent signals to perinuclear sites (Fig. 5b, c and f). The co-
localization suggests that DND1 and APOBEC3 likely sequester
each other.
Figure 5. Mouse DND1 and APOBEC3 co-localize to peri-nuclear sites in the cell cytoplasm. (a) COS7 cells were transfected with
expression constructs for GFP-Dnd1 for visualization of green fluorescence due to GFP-DND1. Cells were fixed with 2% paraformaldehyde before
visualization of fluorescent signal by confocal microscopy. (d) COS7 cells were transfected with expression constructs for mCherry-Apobec3 for
visualization of red fluorescence due to mCherry-Apobec3 by confocal microscopy. (b,c,e and f) COS7 cells were co-transfected with expression
constructs for GFP-DND1 and mCherry-Apobec3. (b) Red fluorescence due to mCherry-APOBEC3 was imaged using red filter (excitation at 548 nm).
(c) Green fluorescence due to GFP-DND1 was imaged using green filter (excitation at 488 nm). (f) The merged image of cells co-transfected with GFP-
Dnd1 and mCherry-Apobec3, which shows GFP and mCherry signal co-localized at the peri-nuclear regions of the cells. (e) The DIC (differential
interference contrast) image of the cells.
doi:10.1371/journal.pone.0002315.g005
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and mCherry-APOBEC3 were expressed in the cell cytoplasm, the
sequestration of GFP-DND1 and mCherry-APOBEC3 to perinu-
clear regions was somewhat less obvious in NIH3T3 cells (Fig. 6a,
b and d) and less so in 293T cells (Fig. 6 e, g and f). One
explanation as to why we observed co-localization and sequestra-
tion in COS7 but not in 293T cells could be because COS7 cells
may harbor cellular factors that facilitate sequestration of GFP-
DND1 and mCherry-APOBEC3. The confocal microscopy results
of DND1 and APOBEC3 localization were identical when GFP or
mCherry were cloned either as N-terminus or C-terminal fusion
proteins to DND1 or APOBEC3, respectively (data not shown).
Human GFP-APOBEC3 orthologs (APOBEC3D, APOBEC3F
and APOBEC3G) have been reported to be expressed in the
cytoplasm [38,33] similar to the distribution that we observe for
mouse APOBEC3. More detailed studies show that human
APOBEC3 localizes to cytoplasmic bodies P-bodies and stress
granules [29,31]. Future work will examine if both DND1 and
APOBEC3 also localize to P-bodies in cells.
In our transfection experiments using fluorescently-tagged
APOBEC3, we did not observe localization of mCherry-
APOBEC3 to discreet cytoplasmic bodies but to be generally
present in the cytoplasm (Fig. 5d). Thus, our results are somewhat
different from reports of APOBEC3 localization to discreet
cytoplasmic bodies [29]. This difference in observations could be
due to variability in cell lines, transfection conditions or because
mouse APOBEC3 was used in our studies as opposed to human
APOBEC3G in the other studies.
Discussion
APOBEC3 interacts with DND1
We have used several experimental methods to demonstrate
that DND1 interacts with APOBEC3 in vitro as well as in vivo in
mammalian cells and tissues. First, APOBEC3, generated in vitro,
interacts specifically with DND1. We ruled out the presence of
contaminating RNA or DNA in the in vitro translation mix that
facilitates DND1-APOBEC3 interaction. We observed that mouse
and human APOBEC1 were also able to bind to DND1 but there
was significant non-specific binding of APOBEC1 to the
Sepharose 4B beads as well. This suggests that APOBEC1 may
also interact with DND1, although the interaction may be weaker
and with lower affinity.
Second, DND1 pulled-down APOBEC3 from mammalian cells
when tagged proteins were generated in transfected cells. Thus,
DND1 and APOBEC3 are found in the same protein complex in
mammalian cells. Recent reports indicate that human APO-
BEC3G interacts with a number of cellular proteins with RNA
binding domains [29,31]. In most cases, direct interaction between
APOBEC3G and the proteins did not appear to be the case and
the interaction between the proteins was likely through some
shared mRNA. In other cases, for example, interaction of
APOBEC3 with the proteins, Argonaute-1 and Argonaute-2,
appeared not to be facilitated by RNA because the interaction was
RNAse-resistant [29]. In the same study, 293T cells transfected
with tagged-APOBEC3G resulted in the ‘pull-down’ and identi-
fication of a number of other cellular protein(s) [29] many of which
were RNA binding proteins. Among the other proteins that were
‘pulled-down’ together with APOBEC3G was the HuR protein.
HuR is an AU-rich element binding protein which has been
shown to bind to the 39-UTR of CAT-1 mRNA to prohibit access
to miR-122 [39]. Thus, HuR is another RNA binding protein with
a functional role similar to DND1.
Third, our studies demonstrate that GST-DND1 pulls-down
endogenous APOBEC3 from mouse testes. In this case, pull-down
of the endogenous, mouse testes APOBEC3 was more effective by
DND1a compared to DND1b. This was unlike the interaction of
in vitro translated APOBEC3 with GST-DND1a and GST-
DND1b, where both isoforms were equally able to interact with
APOBEC3. One explanation for this is that testes APOBEC3 may
be post-translationally modified such that it influences its
interaction with DND1a or DND1b.
Fourth,fluorescent-protein tagged DND1and APOBEC3proteins
sequestered near peri-nuclear sites in COS7 cells. This phenomenon
appears to be cell specific and was observed in COS7 cells but not in
some other cell types. An explanation for this may be that additional
cellular factors present in COS7 are responsible for mediating
sequestration of DND1 and APOBEC3. The pull-down experiments
of DND1 with APOBEC3 do not unambiguously indicate a direct
interaction of the two proteins. However, taking into consideration
the cell-type specific sequestration of fluorescently tagged DND1 and
APOBEC3, it suggests that the interaction of DND1 and APOBEC3
may likely be mediated by other factors in the cell.
Studies by three independent groups report the localization of
human APOBEC3G to P-bodies and stress granules in 293T cells
Figure 6. Localization of APOBEC3 and DND1 in NIH3T3 and 293T cells. (a–d) Co-transfection of mCherry-Apobec3 and GFP-DND1
expression constructs into NIH3T3 cells. Cells were fixed with 2% paraformaldehyde before visualization of fluorescent signal by confocal microscopy.
(a) Red fluorescence due to mCherry-APOBEC3 was imaged using red filter (excitation at 548 nm); (b) green fluorescence due to GFP-DND1 was
imaged using green filter (excitation at 488 nm); (d) merged image of red and green filters showing APOBEC3 and DND1 co-localize (yellow signal)
near perinuclear region in NIH3T3 cells. (c) The DIC (differential interference contrast) image of the cells. (e–g) Co-transfection of mCherry-Apobec3
and GFP-DND1 expression constructs into 293T cells. Cells were fixed with 2% paraformaldehyde before visualization of fluorescent signal by confocal
microscopy. (e) Image of red fluorescence due to mCherry-APOBEC3 (red filter; excitation at 548 nm); (g) green fluorescence due to GFP-DND1
(green filter, excitation at 488 nm) and (f) merged image of red and green filters showing APOBEC3 and DND1 co-localize to cytoplasm in 293T cells.
doi:10.1371/journal.pone.0002315.g006
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activity of APOBEC3G is likely inhibited in these cytoplasmic
granules [40,28,30]. In light of this, the consequence of DND1-
APOBEC3 interaction for either APOBEC3 or DND1 function
remains to be elucidated.
In addition to the experimental demonstration of DND1-
APOBEC3 interaction, we found that both Dnd1 and Apobec3
transcripts are detected in germ cells and in the developing
embryonic gonads. The transcripts are present in germ cells and in
genital ridges during embryonic stages when DND1 function is
required for germ cell viability. Moreover, lack of Dnd1 at these
embryonic stages also results in initiation of germ cell tumors in
the 129 strain male [5,7].
Potential function of DND1-APOBEC3 interaction
One function of APOBEC3 is that it is an antiretroviral factor
and inactivates exogenous and endogenous retroviruses [20].
Human APOBEC3 (APOBEC3G) suppresses a variety of
retroviruses including Vif (virion infectivity factor)-deficient
human immunodeficiency virus type 1 (HIV-1) [41–44,38,45–
52]. APOBEC3 also restricts transposition of endogenous retro-
transposons such as MusD, intracisternal A-particle (IAP) [53,20]
and long interspersed nuclear elements, LINE-1 (L1) [54–56,33].
Although cytidine deamination appears to be the primary
mechanism by which APOBEC3 inhibits retrovirus replication
[43,38,46,50], there is also a large body of evidence suggesting
some novel, yet undefined, deaminase independent mechanism for
the antiviral function of APOBEC3 [54–56,33]. Mouse APO-
BEC3 has also been shown to have anti-retroviral activity [20].
Mouse APOBEC3 has two cytidine deaminase domains (CDD)
[57,19]. The proximal CDD is involved in deamination whereas
the distal CDD is involved in dimerization of APOBEC3 proteins
and for viral encapsidation [57].
Recent reports indicate additional cellular functions of APO-
BEC3. APOBEC3 is able to inhibit miRNA-mediated repression
of mRNA. APOBEC3 appears to allow mRNA to move from P-
granules to polysomes [28].
The role of APOBEC3 in suppressing miRNA mediated mRNA
repression parallels recent reports on the role of DND1 in
suppressing miRNA-mediated mRNA repression [8]. It is not
clear if DND1 sequesters mRNA to prevent its access to miRNA
or whether DND1 physically displaces miRNA RISC complex
from mRNA [8,12]. In this respect, it will be important to examine
if DND1 and APOBEC3 function synergistically or antagonisti-
cally to modulate miRNA function.
The inactivating mutation in the Dnd1 gene in Ter mice causes
either sterility or testicular germ cell tumor development. We
report here that DND1 interacts with APOBEC3. The functional
consequences of DND1 interaction with APOBEC3 remains to be
established. One possibility is that DND1 may modulate some
specific antiviral or anti-retrotransposion activity of APOBEC3.
DND1 may be a cellular factor that is necessary for regulating
some aspect of APOBEC3 activity, especially in germ cells.
Another possibility is that DND1 and APOBEC3 function
synergistically or antagonistically to modulate miRNA mediated
repression of mRNA. The 39-UTR of mRNAs generally contains
multiple miRNA binding sites as well as binding sites for different
RNA binding proteins. In light of the reports that both DND1 and
APOBEC3 bind to mRNA to inhibit miRNA mediated repression,
and taking into consideration our observation of DND1-
APOBEC3 interaction, our studies implicate a possible role of
DND1-APOBEC3 interaction in modulating miRNA-mediated
mRNA repression. Understanding the role of DND1-APOBEC3
interaction will not only shed light on the development of testicular
germ cell tumors in mice and humans but may also have profound
implications for our understanding of the mechanism of how
cancers in general originate in humans.
Materials and Methods
Cell Lines
NIH3T3, COS7 and human embryonic kidney (HEK) 293T
cells were from ATCC.
RT-PCR of APOBEC transcripts
RT-PCR was performed as described [32] to amplify Apobec-1,
Apobec-2 and Apobec-3 cDNA from 129 testes mRNA. Primers
flanking the start and stop codons of each gene were used for the
amplifications and were as follows:
Apo1-F: 59-cagagcaagatgagttccgagac-39 and
Apo1-R: 59-caactcccagaagtcatttc-39 for Apobec-1;
Apo2-F : 59-cacagttcctccatggctcaga-39 and
Apo2-R: 59-cgagctctgttgcctacttcag-39 for Apobec-2;
Apo3-F: 59-cagagctgggatgggaccattctg-39 and
Apo3-R: 59-gaatctcttcttgcctctcaagac-39 for Apobec-3;
Aicd-F 59-gaccgatatggacagccttctg-39 and
Aicd-R 59-gctttcaaaatcccaacatac-39 for AICD.
In vitro transcription and translation
The full-length cDNA of the Apobecs were cloned into pBK-
CMV, sequence verified and used as templates in in vitro
transcription/translation reactions. TnT Coupled Reticulocyte
Lysate Systems (Promega) was used to generate [
35S]methionine-
labeled APOBEC proteins in in vitro transcription/translation
reactions. The labeled proteins were analyzed on NuPAGE-Mes
gels (Invitrogen). 25% of the translated proteins were loaded for
analysis in each lane of the gel. The transcription/translation
reactions of equal amounts the Apobec1, Apobec2 and Apobec3
templates generated [
35S]methionine-labeled proteins of the
expected sizes, as determined by electrophoreses. The calculated
molecular weight for APOBEC1 is 25.5 KDa, 25.7 KDa for
APOBEC2, 47.4 KDa for APOBEC3 protein containing 8 exons
and 51 KDa for APOBEC3 protein containing 9 exons. For
controls, human APOBEC1 (hA1) (calculated molecular weight,
22.8 KDa) and human ACF (65 KDa) were also generated by in
vitro transcription/translation of cloned expression constructs.
Generation and purification of GST-DND1
The cDNA of the two isoforms of mouse DND1 (isoforms a and
b) were cloned in-frame into pGEX-2TK (amersham pharmacia
biotech) [32]. The GST(glutathione S-transferase)-DND1 fusion
proteins were induced by IPTG (isopropyl-b-D-thiogalactoside),
extracted from bacteria by sonication and affinity purified using
Glutathione Sepharose 4B beads. GST proteins were also
generated in a similar manner for use in control reactions.
In vitro interaction reactions
Equal amounts of Apobec cDNA cloned into pBK-CMV (1 mg)
were used as templates in in vitro transcription/translation
reactions (TnT Coupled Reticulocyte Lysate Systems, Promega)
to generate [
35S]methionine-labeled APOBEC proteins in a total
volume of 100 mL. The amount of each [
35S]methionine-labeled
APOBEC protein generated in the reaction was determined by
electrophoreses of 5 mL on a gel.
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35S]methionine-labeled
APOBEC proteins were placed into two tubes. One tube of the
[
35S]methionine-labeled APOBEC proteins was incubated with
purified GST-DND1 and Glutathione (GST) Sepharose 4B beads.
The second tube (control) was incubated with beads only.
Glutathione Sepharose 4B binds to GST and GST-fusion proteins
(in this case, GST-DND1) and should therefore ‘‘pull-down’’
proteins that associate with GST-DND1. At the end of the
incubation period, the tubes were centrifuged to pellet the
Sepharose 4B beads. The beads were washed to reduce non-
specific binding. Loading dye was added to the beads before
heating to 95
0C to release the proteins from the beads into the
loading dye. Equal volumes of the loading dye were electropho-
resed on NuPAGE-Mes gels (Invitrogen) to assess the binding of
the radiolabelled APOBEC proteins to GST-DND1.
To test whether the in vitro binding of GST-DND1 to
APOBEC3 is dependent on RNA or DNA that may be present
in the in vitro transcription/translation reactions, [
35S]labeled
APOBEC-3-GST-DND1 complexes were treated for 1 h with
0.08 U RNase (RNAse, DNase-free from bovine pancreas, Roche)
or 5 U DNase (DNAse 1, RNase-free from bovine pancreas).
Pull-down of APOBEC3 with DND1 in mammalian cells
Dnd1 and Apobec cDNAs were cloned in frame into mammalian
expression vectors (pCMV-HA or pCMV-Myc, Clontech) to
generate HA(hemagglutinin) epitope-tagged DND1 or myc-tagged
APOBEC proteins. Both HA-Dnd1 and myc-Apobec plasmid
constructs were co-transfected into human embryonic kidney
(HEK) 293T cells. The transfected 293T cells were lysed after
48 h, and immunoprecipitation using anti-HA antibody (abm) was
performed to ‘‘pull-down’’ HA-DND1 and associated proteins.
After electrophoresis and transfer to membranes, western blotting
was performed using anti-myc antibody (Invitrogen). Control
aliquots of cell lysates were not incubated with antibody.
RNA isolation from EG cells and genital ridges
EG cells were isolated from hybrid strains of B6C3 F1 mice
[35]. The cells were grown on mitomycin C-treated mouse
embryo fibroblasts. While in culture, some EG cell plates were
periodically stained with alkaline phosphatase chromogen (abcam)
to ensure they had not differentiated.
RNA isolation from male genital ridges from 129 mouse
embryos at E13.5 stages was as described [32].
Fluorescent protein tagged-APOBEC3 and DND1
Mouse Dnd1 was cloned in frame and fused to fluorescent GFP
(green fluorescent protein) either in the N or C-terminus in
pEGFp-N3 (Clontech) and pEGFP-C1 (Clontech) vectors. Mouse
Apobec3 (9-exon isoform) was cloned in frame and fused to
monomeric cherry fluorescent protein (mCherry) in the pRSET-B
mCherry vector [58]. The cherry fluorescent protein was
substituted into the ECFP sites in the pECFP-C1 (Clontech) and
pECFP-N1 (Clontech) vectors so the multiple cloning sites of C1
and N1 could be used to clone in and generate C and N-terminal
cherry fusion products.
The GFP-Dnd1 and mCherry-Apobec-3 were transfected sepa-
rately into 293T or COS7 cells. After 20 hours, transfected cells
were fixed with 2% paraformaldehyde before visualization of
fluorescent signal by Zeiss LSM 510 Confocal Microscope. Green
fluorescence due to GFP-DND1 was imaged using green filter
(excitation at 488 nm); red fluorescence due to mCherry-
APOBEC-3 was imaged using red filter (excitation at 548 nm).
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